TLPH vs. SYBX, TCRT, MEIP, INDP, COCP, BIVI, KALA, VBIV, SLGL, and ORGS
Should you be buying Talphera stock or one of its competitors? The main competitors of Talphera include Synlogic (SYBX), Alaunos Therapeutics (TCRT), MEI Pharma (MEIP), Indaptus Therapeutics (INDP), Cocrystal Pharma (COCP), BioVie (BIVI), KALA BIO (KALA), VBI Vaccines (VBIV), Sol-Gel Technologies (SLGL), and Orgenesis (ORGS). These companies are all part of the "pharmaceutical preparations" industry.
Synlogic (NASDAQ:SYBX) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, community ranking, analyst recommendations, risk and earnings.
Talphera has lower revenue, but higher earnings than Synlogic. Talphera is trading at a lower price-to-earnings ratio than Synlogic, indicating that it is currently the more affordable of the two stocks.
In the previous week, Talphera had 4 more articles in the media than Synlogic. MarketBeat recorded 14 mentions for Talphera and 10 mentions for Synlogic. Synlogic's average media sentiment score of 0.50 beat Talphera's score of -0.16 indicating that Talphera is being referred to more favorably in the news media.
Synlogic received 327 more outperform votes than Talphera when rated by MarketBeat users. However, 100.00% of users gave Talphera an outperform vote while only 69.54% of users gave Synlogic an outperform vote.
Talphera has a net margin of 0.00% compared to Talphera's net margin of -2,284.65%. Synlogic's return on equity of -96.30% beat Talphera's return on equity.
63.4% of Synlogic shares are held by institutional investors. Comparatively, 37.7% of Talphera shares are held by institutional investors. 8.0% of Synlogic shares are held by company insiders. Comparatively, 3.0% of Talphera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Synlogic currently has a consensus price target of $65.00, suggesting a potential upside of 3,815.66%. Talphera has a consensus price target of $4.50, suggesting a potential upside of 314.75%. Given Talphera's higher possible upside, equities research analysts clearly believe Synlogic is more favorable than Talphera.
Synlogic has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. Comparatively, Talphera has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500.
Summary
Talphera beats Synlogic on 11 of the 18 factors compared between the two stocks.
Get Talphera News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TLPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Talphera Competitors List
Related Companies and Tools
